LC
RMD icon

Lindbrook Capital’s ResMed RMD Stock Holding History

Lindbrook Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$280K Buy
1,249
+244
+24% +$57K 0.03% 325
2024
Q4 		$230K Hold
1,005
– – 0.02% 360
2024
Q3 		$245K Buy
1,005
+22
+2% +$4.92K 0.02% 346
2024
Q2 		$188K Buy
983
+35
+4% +$7.1K 0.02% 375
2024
Q1 		$188K Buy
948
+31
+3% +$5.68K 0.02% 371
2023
Q4 		$158K Buy
917
+471
+106% +$72.4K 0.02% 392
2023
Q3 		$66K Buy
446
+28
+7% +$5.06K 0.01% 595
2023
Q2 		$91.3K Sell
418
-17
-4% -$3.79K 0.01% 510
2023
Q1 		$95.3K Buy
435
+76
+21% +$16.5K 0.01% 490
2022
Q4 		$74.7K Sell
359
-23
-6% -$5.05K 0.01% 568
2022
Q3 		$83K Buy
382
+32
+9% +$7.28K 0.01% 495
2022
Q2 		$73K Buy
350
+41
+13% +$8.73K 0.01% 534
2022
Q1 		$75K Buy
309
+28
+10% +$6.77K 0.01% 556
2021
Q4 		$73K Sell
281
-653
-70% -$169K 0.01% 596
2021
Q3 		$246K Buy
934
+5
+0.5% +$1.37K 0.06% 126
2021
Q2 		$229K Hold
929
– – 0.05% 148
2021
Q1 		$180K Buy
929
+6
+0.7% +$1.2K 0.04% 170
2020
Q4 		$196K Buy
923
+3
+0.3% +$598 0.05% 143
2020
Q3 		$158K Buy
920
+3
+0.3% +$554 0.04% 147
2020
Q2 		$176K Sell
917
-18
-2% -$2.94K 0.05% 134
2020
Q1 		$138K Buy
935
+18
+2% +$2.87K 0.05% 145
2019
Q4 		$142K Buy
917
+24
+3% +$3.46K 0.05% 192
2019
Q3 		$121K Hold
893
– – 0.05% 203
2019
Q2 		$108K Hold
893
– – 0.04% 219
2019
Q1 		$92K Hold
893
– – 0.04% 240
2018
Q4 		$101K Buy
+893
New +$95.7K 0.05% 198

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Lindbrook Capital's RMD Position: Q1 2025 in Review

Lindbrook Capital increased its ResMed (RMD) stake by 24% in Q1 2025, buying an estimated $57K and bringing the position to 1,249 shares worth $280K. The position accounts for 0.03% of the portfolio, ranked #325.

Lindbrook Capital first reported a position in RMD in Q4 2018 and has held it in 26 quarters since. 886 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Lindbrook Capital held 1,249 shares of ResMed worth $280K as of Q1 2025.
  • Lindbrook Capital bought 244 ResMed shares in Q1 2025, an estimated $57K.
  • ResMed made up 0.03% of Lindbrook Capital's portfolio in Q1 2025, its #325 holding.
  • Lindbrook Capital first reported a position in ResMed in Q4 2018 and has held it in 26 quarters since.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.